PLX108-01

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLX108-01, covering 2020-04-06 to 2020-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of PLX108-01 in Patients With Solid Tumors [Phase 1]